1. Home
  2. CTKB vs PSBD Comparison

CTKB vs PSBD Comparison

Compare CTKB & PSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • PSBD
  • Stock Information
  • Founded
  • CTKB 1990
  • PSBD 2009
  • Country
  • CTKB United States
  • PSBD United States
  • Employees
  • CTKB N/A
  • PSBD N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PSBD
  • Sector
  • CTKB Health Care
  • PSBD
  • Exchange
  • CTKB Nasdaq
  • PSBD Nasdaq
  • Market Cap
  • CTKB 430.6M
  • PSBD 454.5M
  • IPO Year
  • CTKB 2021
  • PSBD 2024
  • Fundamental
  • Price
  • CTKB $3.69
  • PSBD $13.64
  • Analyst Decision
  • CTKB Hold
  • PSBD Buy
  • Analyst Count
  • CTKB 4
  • PSBD 4
  • Target Price
  • CTKB $6.00
  • PSBD $14.25
  • AVG Volume (30 Days)
  • CTKB 960.6K
  • PSBD 38.0K
  • Earning Date
  • CTKB 08-05-2025
  • PSBD 08-06-2025
  • Dividend Yield
  • CTKB N/A
  • PSBD 12.58%
  • EPS Growth
  • CTKB N/A
  • PSBD N/A
  • EPS
  • CTKB N/A
  • PSBD N/A
  • Revenue
  • CTKB $197,050,000.00
  • PSBD N/A
  • Revenue This Year
  • CTKB $0.91
  • PSBD N/A
  • Revenue Next Year
  • CTKB $7.75
  • PSBD N/A
  • P/E Ratio
  • CTKB N/A
  • PSBD N/A
  • Revenue Growth
  • CTKB N/A
  • PSBD N/A
  • 52 Week Low
  • CTKB $2.37
  • PSBD $11.51
  • 52 Week High
  • CTKB $7.63
  • PSBD $16.85
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 60.88
  • PSBD 36.64
  • Support Level
  • CTKB $3.20
  • PSBD $13.87
  • Resistance Level
  • CTKB $3.44
  • PSBD $14.27
  • Average True Range (ATR)
  • CTKB 0.18
  • PSBD 0.33
  • MACD
  • CTKB 0.01
  • PSBD -0.05
  • Stochastic Oscillator
  • CTKB 96.77
  • PSBD 2.40

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About PSBD Palmer Square Capital BDC Inc.

Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.

Share on Social Networks: